249 related articles for article (PubMed ID: 21482089)
21. Ligation of CD5 on resting B cells, but not on resting T cells, results in apoptosis.
Pers JO; Jamin C; Le Corre R; Lydyard PM; Youinou P
Eur J Immunol; 1998 Dec; 28(12):4170-6. PubMed ID: 9862353
[TBL] [Abstract][Full Text] [Related]
22. Interaction of recombinant and natural soluble CD5 forms with an alternative cell surface ligand.
Calvo J; Places L; Padilla O; Vilà JM; Vives J; Bowen MA; Lozano F
Eur J Immunol; 1999 Jul; 29(7):2119-29. PubMed ID: 10427974
[TBL] [Abstract][Full Text] [Related]
23. CD5+ B cell-dependent regulation of the murine T-cell independent immune response against the human blood group A antigen.
Néron S; Lemieux R
Immunol Invest; 1997; 26(5-7):631-47. PubMed ID: 9399105
[TBL] [Abstract][Full Text] [Related]
24. The accessory molecules CD5 and CD6 associate on the membrane of lymphoid T cells.
Gimferrer I; Farnós M; Calvo M; Mittelbrunn M; Enrich C; Sánchez-Madrid F; Vives J; Lozano F
J Biol Chem; 2003 Mar; 278(10):8564-71. PubMed ID: 12473675
[TBL] [Abstract][Full Text] [Related]
25. Selection of the alternative exon 1 from the cd5 gene down-regulates membrane level of the protein in B lymphocytes.
Garaud S; Le Dantec C; Berthou C; Lydyard PM; Youinou P; Renaudineau Y
J Immunol; 2008 Aug; 181(3):2010-8. PubMed ID: 18641338
[TBL] [Abstract][Full Text] [Related]
26. Post-thymic regulation of CD5 levels in human memory T cells is inversely associated with the strength of responsiveness to interleukin-15.
Herndler-Brandstetter D; Brunner S; Weiskopf D; van Rijn R; Landgraf K; Dejaco C; Duftner C; Schirmer M; Kloss F; Gassner R; Lepperdinger G; Grubeck-Loebenstein B
Hum Immunol; 2011 Aug; 72(8):627-31. PubMed ID: 21539877
[TBL] [Abstract][Full Text] [Related]
27. Modulation of IgD and CD20 by ligation of CD5 on tonsillar B cells.
Morikawa K; Torii I; Morikawa S
Scand J Immunol; 2002 Jan; 55(1):44-52. PubMed ID: 11841691
[TBL] [Abstract][Full Text] [Related]
28. CD5 plays an inhibitory role in the suppressive function of murine CD4(+) CD25(+) T(reg) cells.
Dasu T; Qualls JE; Tuna H; Raman C; Cohen DA; Bondada S
Immunol Lett; 2008 Aug; 119(1-2):103-13. PubMed ID: 18573278
[TBL] [Abstract][Full Text] [Related]
29. Expression of CD5 on B lymphocytes correlates with disease activity in patients with multiple sclerosis.
Seidi OA; Semra YK; Sharief MK
J Neuroimmunol; 2002 Dec; 133(1-2):205-10. PubMed ID: 12446024
[TBL] [Abstract][Full Text] [Related]
30. The ectodomains of the lymphocyte scavenger receptors CD5 and CD6 interact with tegumental antigens from Echinococcus granulosus sensu lato and protect mice against secondary cystic echinococcosis.
Mourglia-Ettlin G; Miles S; Velasco-De-Andrés M; Armiger-Borràs N; Cucher M; Dematteis S; Lozano F
PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006891. PubMed ID: 30500820
[TBL] [Abstract][Full Text] [Related]
31. CD5 as a Target for Immune-Based Therapies.
Consuegra-Fernández M; Aranda F; Simões I; Orta M; Sarukhan A; Lozano F
Crit Rev Immunol; 2015; 35(2):85-115. PubMed ID: 26351145
[TBL] [Abstract][Full Text] [Related]
32. Tolerance without clonal expansion: self-antigen-expressing B cells program self-reactive T cells for future deletion.
Frommer F; Heinen TJ; Wunderlich FT; Yogev N; Buch T; Roers A; Bettelli E; Müller W; Anderton SM; Waisman A
J Immunol; 2008 Oct; 181(8):5748-59. PubMed ID: 18832734
[TBL] [Abstract][Full Text] [Related]
33. Characterization of porcine CD5 and CD5+ B cells.
Appleyard GD; Wilkie BN
Clin Exp Immunol; 1998 Jan; 111(1):225-30. PubMed ID: 9472686
[TBL] [Abstract][Full Text] [Related]
34. IL10 restrains autoreactive B cells in transgenic mice expressing inactive RAG1.
Palmer VL; Worth AN; Scott RL; Perry GA; Yan M; Li QZ; Swanson PC
Cell Immunol; 2018 Sep; 331():110-120. PubMed ID: 30017086
[TBL] [Abstract][Full Text] [Related]
35. CD5 expression promotes IL-10 production through activation of the MAPK/Erk pathway and upregulation of TRPC1 channels in B lymphocytes.
Garaud S; Taher TE; Debant M; Burgos M; Melayah S; Berthou C; Parikh K; Pers JO; Luque-Paz D; Chiocchia G; Peppelenbosch M; Isenberg DA; Youinou P; Mignen O; Renaudineau Y; Mageed RA
Cell Mol Immunol; 2018 Feb; 15(2):158-170. PubMed ID: 27499044
[TBL] [Abstract][Full Text] [Related]
36. Preferential localization of human CD5+ B cells in the peritoneal cavity.
Nisitani S; Murakami M; Akamizu T; Okino T; Ohmori K; Mori T; Imamura M; Honjo T
Scand J Immunol; 1997 Dec; 46(6):541-5. PubMed ID: 9420615
[TBL] [Abstract][Full Text] [Related]
37. An alternative exon 1 of the CD5 gene regulates CD5 expression in human B lymphocytes.
Renaudineau Y; Hillion S; Saraux A; Mageed RA; Youinou P
Blood; 2005 Oct; 106(8):2781-9. PubMed ID: 15998834
[TBL] [Abstract][Full Text] [Related]
38. Reversible Transgene Expression Reduces Fratricide and Permits 4-1BB Costimulation of CAR T Cells Directed to T-cell Malignancies.
Mamonkin M; Mukherjee M; Srinivasan M; Sharma S; Gomes-Silva D; Mo F; Krenciute G; Orange JS; Brenner MK
Cancer Immunol Res; 2018 Jan; 6(1):47-58. PubMed ID: 29079655
[TBL] [Abstract][Full Text] [Related]
39. Long-term survival of hamster-to-rat heart xenografts based on mechanisms of accommodation and tolerance of CD5 B cells.
Lin Y; Goebels J; Vandeputte M; Waer M
Transplant Proc; 1997 Aug; 29(5):2355. PubMed ID: 9270761
[No Abstract] [Full Text] [Related]
40. Characterization of the mitogenic response of murine CD5+ and conventional B lymphocytes to lipopolysaccharide.
Philips JR; Massey WL; Hunter N
Immunol Cell Biol; 1998 Aug; 76(4):332-42. PubMed ID: 9723774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
